Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bladder Cancer

  Free Subscription


Articles published in Prog Urol

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    May 2022
  1. DOBE TR, Belhadj Y, Michel C, Djouadou M, et al
    Perioperative results of radical cystectomy after neoadjuvant chemotherapy according to the implementation of ERAS pathway.
    Prog Urol. 2022;32:401-409.
    PubMed     Abstract available


  2. EL AZAB A, Hossam E, Abdelrahman I, Aboulkassem H, et al
    Variables affecting quality of life after Radical cystectomy and neobladder substitution: Egyptian National Cancer Institute experience.
    Prog Urol. 2022;32:410-418.
    PubMed     Abstract available


    April 2022
  3. ROLLIN P, Xylinas E, Lanz C, Audenet F, et al
    [Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie].
    Prog Urol. 2022;32:326-331.
    PubMed     Abstract available


    March 2022
  4. AUDENET F, Sotto A, Roumiguie M, Allory Y, et al
    [Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG].
    Prog Urol. 2022;32:165-176.
    PubMed     Abstract available


    February 2022
  5. LEON P, Saint F, Audenet F, Roumiguie M, et al
    [Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].
    Prog Urol. 2022 Feb 9. pii: S1166-7087(22)00011.
    PubMed     Abstract available


    January 2022
  6. MESSAOUD M, Vercherin P, Chaneliere AF, Mottet N, et al
    [Geriatric assessment and treatment of nonmetastatic muscle-invasive bladder cancer in patients over 75 years of age. Retrospective and multicentric study of 121 cases].
    Prog Urol. 2022 Jan 5. pii: S1166-7087(21)00582.
    PubMed     Abstract available


  7. SOOROJEBALLY Y, Surlemont L, Neuzillet Y, Lebret T, et al
    Impact of carcinoma in situ on survival of patients treated by adjuvant chemotherapy after cystectomy.
    Prog Urol. 2022;32:53-60.
    PubMed     Abstract available


    September 2021
  8. ROUX S, Pettenati C, Dariane C, Sbizzera M, et al
    Management of long ureteral stenosis: Alternatives to indwelling ureteral stents.
    Prog Urol. 2021;31:598-604.
    PubMed     Abstract available


    August 2021
  9. CAMPAGNA J, Touzani R, Gravis G, Marino P, et al
    [Does the announcement of cancer at the time of Non Muscle-Invasive Bladder Cancer diagnosis affect quality of life and adherence of patients? Data from the French prospective cohort VICAN].
    Prog Urol. 2021 Aug 27. pii: S1166-7087(21)00213.
    PubMed     Abstract available


    May 2021
  10. SAINT F, Masson-Lecomte A
    Achieving disease free distal ureteral margin at the time of radical cystectomy: Why and for whom? (an overview of literature).
    Prog Urol. 2021;31:303-315.
    PubMed     Abstract available


  11. SURLEMONT L, Nouhaud FX, Dupuis H, Delcourt C, et al
    [BCG strain shortage from 2012 to 2014: Evaluation of its impact on the management of patients with high-risk NMIBC].
    Prog Urol. 2021;31:324-331.
    PubMed     Abstract available


    March 2021
  12. GONDRAN-TELLIER B, Abdallah R, Sichez PC, Akiki A, et al
    Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer.
    Prog Urol. 2021 Mar 1. pii: S1166-7087(21)00028.
    PubMed     Abstract available


    January 2021
  13. SUCH M, Lavolle A, Popelin MB, Thibault C, et al
    Administration of neoadjuvant chemotherapy for muscle-invasive bladder cancer in real life: Are urologists still too cautious?
    Prog Urol. 2021 Jan 16. pii: S1166-7087(20)30742.
    PubMed     Abstract available


    December 2020
  14. PIGNOT G, Sargos P
    [Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer].
    Prog Urol. 2020 Dec 23. pii: S1166-7087(20)30741.
    PubMed     Abstract available


    November 2020
  15. ROUPRET M, Pignot G, Masson-Lecomte A, Comperat E, et al
    [French ccAFU guidelines - update 2020-2022: bladder cancer].
    Prog Urol. 2020;30.
    PubMed     Abstract available


    September 2020
  16. BRETON J, Bernardeau S, Vallee M, Pillot P, et al
    [Single, immediate postoperative intra-vesical instillation (SI) compared to a single preoperative intra-vesical instillation of mitomycin C in non-muscle invasive bladder cancer (NMIBC). Phase II randomized trial].
    Prog Urol. 2020 Sep 2. pii: S1166-7087(20)30481.
    PubMed     Abstract available


  17. LIU J, Xie J, Huang Y, Xie J, et al
    TFPI-2 inhibits the invasion and metastasis of bladder cancer cells.
    Prog Urol. 2020 Sep 2. pii: S1166-7087(20)30479.
    PubMed     Abstract available


    April 2020
  18. CARANDO R, Pradere B, Afferi L, Marra G, et al
    The role of device-assisted therapies in the management of non-muscle invasive bladder cancer: A systematic review.
    Prog Urol. 2020 Apr 9. pii: S1166-7087(20)30097.
    PubMed     Abstract available


    February 2020
  19. YANG T, Fan J, Liang H, He D, et al
    Reduced E-cadherin expression as a prognostic factor in non-muscle-invasive bladder cancer: A systematic review and meta-analysis.
    Prog Urol. 2020 Feb 12. pii: S1166-7087(19)30651.
    PubMed     Abstract available


  20. BIARDEAU X, Lamande N, Tondut L, Peyronnet B, et al
    Quality of life associated with orthotopic neobladder and ileal conduit in women: A multicentric cross-sectional study.
    Prog Urol. 2020;30:80-88.
    PubMed     Abstract available


    January 2020
  21. KHAN W, Zugail AS, Blanc E, Neuziller Y, et al
    Reasons for intravesical instillation postponement during adjuvant treatment of non-muscle-invasive bladder cancer: A prospective study.
    Prog Urol. 2020 Jan 14. pii: S1166-7087(19)30642.
    PubMed     Abstract available


  22. BRANCHU B, Leon P, Jeglinschi SC, Durlach A, et al
    [Interest of reTURB for pTa high grade bladder urothelial carcinoma].
    Prog Urol. 2020;30:19-25.
    PubMed     Abstract available


  23. CERF N, Radulescu C, Neuzillet Y, Rouanne M, et al
    [Usefulness of frozen section exams during radical cystectomy for urothelial carcinoma].
    Prog Urol. 2020;30:51-57.
    PubMed     Abstract available


    December 2019
  24. FRAISSE G, Renard Y, Lebacle C, Masson-Lecomte A, et al
    [Is sarcopenia a morbi-mortality factor in the treatment of localized muscle-invasive bladder cancer?]
    Prog Urol. 2019 Dec 6. pii: S1166-7087(19)30610.
    PubMed     Abstract available


  25. JEGLINSCHI S, Schirmann A, Durand M, Sanchez S, et al
    Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: Retrospective study in a French peripheral hospital.
    Prog Urol. 2019 Dec 5. pii: S1166-7087(19)30611.
    PubMed     Abstract available


    November 2019
  26. MARQUETTE T, Walz J, Rybikowski S, Maubon T, et al
    [Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients].
    Prog Urol. 2019 Nov 28. pii: S1166-7087(19)30609.
    PubMed     Abstract available


  27. NEUZILLET Y, Geiss R, Paillaud E, Mongiat-Artus P, et al
    [Optimizing the management of bladder cancer in older patients].
    Prog Urol. 2019;29:849-864.
    PubMed     Abstract available


    September 2019
  28. ROUPRET M, Neuzillet Y, Pignot G, Comperat E, et al
    French ccAFU guidelines - Update 2018-2020: Bladder cancer
    Prog Urol. 2019;28.
    PubMed     Abstract available


    July 2019
  29. ANRACT J, Duquesne I, Montagne P, Sibony M, et al
    [Optical coherence tomography of bladder resection specimen].
    Prog Urol. 2019;29.
    PubMed     Abstract available


    May 2019
  30. DOISY L, Walz J, Fakhfakh S, Rybikowski S, et al
    [Is a routine second transurethral resection of the bladder still necessary after hexaminolevulinate photodynamic diagnosis-assisted TURBT?]
    Prog Urol. 2019;29:332-339.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: